DUBLIN, Nov. 1, 2023 /PRNewswire/ -- The "Global Sciatica Treatment Market 2023-2027" report has been added to ResearchAndMarkets.com's offering.
The global sciatica treatment market is poised for substantial expansion, with an anticipated growth of USD 3.08 billion during the period 2022-2027.
This growth is projected to accelerate at a CAGR of 4.83% during the forecast period. Key drivers of this market growth include the rising awareness about sciatica, an increase in the prevalence of risk factors for sciatica, and regulatory support for pipeline drugs.
Market Segmentation
The sciatica treatment market is segmented based on end-users, products, and geographical landscape:
By End-user
- Hospital
- Clinics
- Others
By Product
- Non-surgical treatment
- Surgical treatment
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
Key Drivers and Trends
The development of clonidine micropellet epidural injections is identified as one of the primary drivers of market growth in the sciatica treatment sector. Additionally, increasing investments in research on sciatica and the growing awareness of physiotherapy as an effective treatment for sciatica are expected to drive significant demand in the market.
Key Players
The global sciatica treatment market features a diverse range of key players, including:
- Amneal Pharmaceuticals Inc.
- Apotex Inc.
- Aurobindo Pharma Ltd.
- Bayer AG
- Dr. Reddy's Laboratories Ltd.
- Elam Pharma Pvt. Ltd.
- Fresenius SE and Co. KGaA
- Glenmark Pharmaceuticals Ltd.
- Hikma Pharmaceuticals PLC
- Johnson & Johnson
- KOLON LIFE SCIENCE
- Lupin Ltd.
- Novartis AG
- Omega Laser Systems Ltd.
- Ozone Pharmaceuticals Ltd.
- Pfizer Inc.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
For more information about this report visit https://www.researchandmarkets.com/r/vfz24y
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article